ReviewBlood cancer journal2025

Fedratinib for the treatment of myelofibrosis: a critical appraisal of clinical trial and "real-world" data.

Adrian Duek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.